Specify a stock or a cryptocurrency in the search bar to get a summary
Vivimed Labs Limited
VIVIMEDLABVivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India. Address: NCC House, (Western Wing), Hyderabad, India, 500 081
Analytics
WallStreet Target Price
11 305.98 INRP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures VIVIMEDLAB
Dividend Analytics VIVIMEDLAB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VIVIMEDLAB
Stock Valuation VIVIMEDLAB
Financials VIVIMEDLAB
Results | 2019 | Dynamics |